后生物 通过凝聚机制抑制Helicobacter pylori粘附和生存
Qinglian Hua1, Jinpeng Hu1, Xiaowen Zhang2
1College of Food Science and Engineering, Ocean University of China, Qingdao 266000, China.
Journal of agricultural and food chemistry
|August 20, 2025
概括
来自Lactobacillus rhamnosus MN45的后生物体与Helicobacter pylori强烈凝聚,抑制其有害活动. 这一发现为抗生素耐药性和H.
科学领域:
- 微生物学
- 胃肠病学
- 生物技术
背景情况:
- 杆菌感染是胃病的主要原因,因抗生素耐药性增加而复杂化.
- 后生菌正在成为H.pylori治疗的安全替代品,但查方法尚未得到充分发展.
研究的目的:
- 开发和应用新的查策略来识别抗H. pylori后生物.
- 研究一个有前途的后生物和H. pylori之间的凝聚机制.
主要方法:
- 使用人工胃汁和AGS细胞模型进行查.
- 使用激光共聚焦和扫描电子显微镜进行可视化.
- 对Lactobacillus rhamnosus MN45进行了比较基因组分析.
主要成果:
- Lactobacillus rhamnosus MN45与H. pylori进行了强烈的凝聚.
- MN45显著降低了H. pylori尿酶活性,毒性因子表达和炎症反应.
- 在酸性条件下凝聚效率稳定,随着时间的推移而增加.
结论:
- 乳酸菌MN45是抗H. pylori后生物治疗的有希望的候选者.
- 这项研究阐明了一种涉及COG1396放大的新型后生物介导凝聚机制.
- 这项研究为开发抗H.pylori新策略提供了基础.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
563
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
563
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
701
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
701
Peptic Ulcer Disease II: Pathophysiology
838
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
838


